Cell Therapeutics, Inc. (CTI) to Provide Company Update on Financial and Regulatory Developments

SEATTLE, June 30 /PRNewswire-FirstCall/ -- On Thursday, July 1, 2010, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to provide an update on company financial and regulatory developments.

Conference Call Numbers Thursday, July 1 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-877-941-6010 (US Participants) 1-480-629-9772 (International) Call-back numbers for post-listening available at 11:30 a.m. Eastern Time: 1-800-406-7325 (US Participants) 1 303 590 3030 (International) Passcode: 4324359# Live audio webcast at http://www.celltherapeutics.com/ will be available for post- listening approximately two hours after call ends. Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 F: 206.272.4434 E: [e-mail] http://www.celltherapeutics.com/press_room Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch Logan T: 206.272.4347 F: 206.272.4434 E: [e-mail] http://www.celltherapeutics.com/investors

Cell Therapeutics, Inc.

CONTACT: Dan Eramian , [phone], cell, [phone], fax,
[phone], [e-mail], or Investors, Ed Bell,
[phone], or Lindsey Jesch Logan, [phone], fax,
[phone], [e-mail], all of Cell Therapeutics, Inc.

Web Site: http://www.celltherapeutics.com/